SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001387131-22-002105
Filing Date
2022-02-17
Accepted
2022-02-17 17:17:16
Documents
1
Period of Report
2022-02-15

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP lederman-form4_021522.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP lederman-form4_021522.xml 4 10978
  Complete submission text file 0001387131-22-002105.txt   12506
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Issuer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TONIX PHARMACEUTICALS HOLDING CORP 509 MADISON AVE., SUITE 306 NEW YORK NY 10022
Business Address
LEDERMAN SETH (Reporting) CIK: 0001563420 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36019 | Film No.: 22649389